Acute Myeloid Leukemia With Myelodysplasia-Related Changes
7 clinical trials · Condition
◉ Watch Acute Myeloid Leukemia With Myelodysplasia-Related Changes
| Record | Firm | Date |
|---|---|---|
| CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old (NCT04269213) | Roswell Park Cancer Institute | 2021-07-29 |
| CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia (NCT04231851) | University of California, Irvine | 2020-02-19 |
| A Post-Marketing Observational Study of VYXEOS™ (NCT03526926) | Jazz Pharmaceuticals | 2018-10-23 |
| Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT03330821) | University of Southern California | 2018-04-18 |
| Personalized NK Cell Therapy in CBT (NCT02727803) | M.D. Anderson Cancer Center | 2016-05-19 |
| Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00416598) | National Cancer Institute (NCI) | 2006-11-15 |
Track Acute Myeloid Leukemia With Myelodysplasia-Related Changes automatically
Every clearance here is in the API, with alerts when new ones post.